Lab Members

Antimicrobial drug discovery using pathogenic Staphylococcus aureus and Acinetobacter baumannii: exploiting components of the bacterial RNA metabolism machinery; characterizing prokaryotic ribonucleases; understanding the impact of the host environment on antibiotic resistance and virulence factor expression. 

mRNA degradosomes, tRNA processing and penicillin binding proteins-4 as targets to develop novel classes of  antibacterial drugs.

Targeting A. baumannii efflux pumps via small molecule inhibitors to improve existing antibiotic treatments' effectiveness and combat adaptive efflux-mediated drug resistance.